HIV-Tat protein decreases several cardiac currents.
HIV-Tat protein acts on the currents by sequestering PIP2.
HIV-Tat prolongs ventricular action potentials in human iPS-derived cardiomyocytes.
Tat-induced reduction in PIP2 may explain QT prolongation in HIV-infected patients.